Onderneming Lexicon Pharmaceuticals, Inc. Nasdaq
Aandelen
US5288721047
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07-07-14 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01-01-99 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-08-21 |
Investor Relations Contact | 45 | 13/11 | |
Tom Garner
PRN | Corporate Officer/Principal | - | 09-10-23 |
Wendy Mcdermott
HRO | Human Resources Officer | - | 01-01-22 |
Comptroller/Controller/Auditor | 56 | 01-06-17 | |
General Counsel | - | 04-11-14 | |
Brian Crum
LAW | General Counsel | 51 | 01-01-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-02-01 |
Ray Debbane
CHM | Chairman | 69 | 01-08-07 |
Director/Board Member | 65 | 28-08-07 | |
Philippe Amouyal
BRD | Director/Board Member | 65 | 01-08-07 |
Judith Swain
BRD | Director/Board Member | 75 | 01-09-07 |
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07-07-14 |
Samuel Barker
BRD | Director/Board Member | 81 | 01-03-00 |
Diane Sullivan
BRD | Director/Board Member | 62 | 28-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 362 972 111 | 357 294 841 ( 98,44 %) | 1 528 008 ( 0,4210 %) | 98,44 % |
Aandeel B | 0 | 2 304 147 | 0 | 0 |
Bedrijfsgegevens
Lexicon Pharmaceuticals, Inc.
2445 Technology Forest Boulevard 11th floor
77381-1160, The Woodlands
+
http://www.lexpharma.com![Adres Lexicon Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/9868.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,61% | 122 mld. | |
+17,75% | 112 mld. | |
+17,23% | 25,91 mld. | |
-24,11% | 19,33 mld. | |
-18,56% | 16,17 mld. | |
-18,47% | 15,56 mld. | |
-47,75% | 14,65 mld. | |
+57,35% | 14,34 mld. | |
+5,62% | 14 mld. |